| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
41,630,000 |
| Market
Cap: |
26.95(M) |
| Last
Volume: |
204,752 |
Avg
Vol: |
429,578 |
| 52
Week Range: |
$0.6474 - $0.6474 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Lannett primarily develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. Co.'s primary products include: Amphetamine IR Tablets, which are used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy; Amphetamine ER Capsules, which are indicated for use to treat ADHD; Dicyclomine Tablets, which are indication for the treatment of functional bowel disorder and irritable bowel syndrome; Fluphenazine Tablets, which are used for the management of manifestations of psychotic disorders; and Levothyroxine Capsules, which are soft gel capsules used to treat patients with hypothyroidism and other conditions.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
216,159 |
| Total Buy Value |
$0 |
$0 |
$0 |
$108,668 |
| Total People Bought |
0 |
0 |
0 |
4 |
| Total Buy Transactions |
0 |
0 |
0 |
5 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Chapman John C |
Director |
– • – |
2022-11-17 |
4 |
B |
$0.51 |
$10,200 |
D/D |
20,000 |
174,324 |
2.39 |
29% |
|
| Lepore Patrick G |
Director |
– • – |
2022-11-10 |
4 |
B |
$0.49 |
$49,000 |
D/D |
100,000 |
587,145 |
2.39 |
29% |
|
| Crew Timothy C |
Chief Executive Officer |
• – – |
2022-11-10 |
4 |
AB |
$0.48 |
$7,200 |
D/D |
15,000 |
604,291 |
|
29% |
|
| Rewolinski Melissa |
Director |
– • – |
2022-09-14 |
4 |
B |
$0.49 |
$15,268 |
D/D |
31,159 |
93,259 |
2.39 |
15% |
|
| Abt John |
Chief Quality and Operations |
• – – |
2022-09-07 |
4 |
D |
$0.47 |
$447 |
D/D |
(950) |
118,825 |
|
- |
|
| Kozlowski John |
VP of Finance & CFO |
• – – |
2022-09-07 |
4 |
D |
$0.47 |
$364 |
D/D |
(775) |
131,798 |
|
- |
|
| Abt John |
Chief Quality and Operations |
• – – |
2022-07-31 |
4 |
D |
$0.58 |
$2,276 |
D/D |
(3,924) |
119,775 |
|
- |
|
| Cavanaugh Maureen |
Senior Vice President and CCOO |
• – – |
2022-07-31 |
4 |
D |
$0.58 |
$3,280 |
D/D |
(5,656) |
143,896 |
|
- |
|
| Crew Timothy C |
Chief Executive Officer |
• – – |
2022-07-31 |
4 |
D |
$0.58 |
$11,233 |
D/D |
(19,368) |
589,291 |
|
- |
|
| Kozlowski John |
VP of Finance & CFO |
• – – |
2022-07-31 |
4 |
D |
$0.58 |
$4,706 |
D/D |
(8,114) |
138,954 |
|
- |
|
| Israel Samuel H |
Chief Legal Officer |
• – – |
2022-07-31 |
4 |
D |
$0.58 |
$5,889 |
D/D |
(10,154) |
156,644 |
|
- |
|
| Abt John |
Chief Quality and Operations |
• – – |
2022-07-29 |
4 |
D |
$0.58 |
$1,043 |
D/D |
(1,798) |
123,699 |
|
- |
|
| Cavanaugh Maureen |
Senior Vice President and CCOO |
• – – |
2022-07-29 |
4 |
D |
$0.58 |
$1,764 |
D/D |
(3,042) |
149,552 |
|
- |
|
| Crew Timothy C |
Chief Executive Officer |
• – – |
2022-07-29 |
4 |
D |
$0.58 |
$5,352 |
D/D |
(9,227) |
608,659 |
|
- |
|
| Kozlowski John |
VP of Finance & CFO |
• – – |
2022-07-29 |
4 |
D |
$0.58 |
$1,931 |
D/D |
(3,330) |
147,068 |
|
- |
|
| Israel Samuel H |
Chief Legal Officer |
• – – |
2022-07-29 |
4 |
D |
$0.58 |
$3,170 |
D/D |
(5,465) |
166,798 |
|
- |
|
| Cavanaugh Maureen |
Senior Vice President and CCOO |
• – – |
2022-07-27 |
4 |
D |
$0.57 |
$2,727 |
D/D |
(4,784) |
152,594 |
|
- |
|
| Kozlowski John |
VP of Finance & CFO |
• – – |
2022-07-27 |
4 |
D |
$0.57 |
$4,045 |
D/D |
(7,096) |
150,398 |
|
- |
|
| Israel Samuel H |
Chief Legal Officer |
• – – |
2022-07-27 |
4 |
D |
$0.57 |
$4,896 |
D/D |
(8,589) |
172,263 |
|
- |
|
| Crew Timothy C |
Chief Executive Officer |
• – – |
2022-07-27 |
4 |
D |
$0.57 |
$9,339 |
D/D |
(16,384) |
617,886 |
|
- |
|
| Abt John |
Chief Quality and Operations |
• – – |
2022-07-27 |
4 |
D |
$0.57 |
$1,892 |
D/D |
(3,319) |
125,497 |
|
- |
|
| Israel Samuel H |
Chief Legal Officer |
• – – |
2022-06-30 |
4 |
A |
$0.49 |
$1,169 |
D/D |
2,386 |
180,852 |
|
- |
|
| Lepore Patrick G |
Director |
– • – |
2022-05-16 |
4 |
B |
$0.54 |
$27,000 |
D/D |
50,000 |
487,145 |
2.39 |
-16% |
|
| Israel Samuel H |
Chief Legal Officer |
• – – |
2022-03-31 |
4 |
A |
$0.67 |
$2,019 |
D/D |
3,013 |
178,466 |
|
- |
|
| Abt John |
Chief Quality and Operations |
• – – |
2022-03-31 |
4 |
A |
$0.67 |
$1 |
D/D |
1 |
128,816 |
|
- |
|
762 Records found
|
|
Page 1 of 31 |
|
|
